logo
[breadcrumb_custom]

Tag: ALLR Stock

ALXO Stock
Stock

Allarity Therapeutics Inc Inc. (ALLR) Price Performance: A Comparative Analysis with Competitors

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -80.95% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -85.42%. Over the past 30 days, the price of ALLR has leaped by -71.15%. And in the last five days, it has fallen by -53.54%. The stock market performance of Allarity Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $3088.00

SLGG
Stock

ALLR’s Stock Market Adventure: -58.99% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -58.99% this year. Over the last six months, there has been a stronger performance of -67.90%. The price of ALLR leaped by -46.50% during the last 30 days period. For the last 5-days stocks have slided -24.94%. Allarity Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $154.40 on 04/14/23,

TOST Stock
Stock

Allarity Therapeutics Inc (ALLR) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Allarity Therapeutics Inc’s current trading price is -99.83% away from its 52-week high, while its distance from the 52-week low is -8.59%. The stock’s price range during this period has varied between $0.29 and $154.40. The company, active in the Healthcare sector, saw a trading volume of around 0.52 million for the day, considerably higher average daily volume of 0.13 million observed over the last three months. Allarity Therapeutics Inc’s stock market performance has been